Valdospan GmbH is a biotechnology company, which develops life-changing medicine for the therapy of virally induced life-threatening infectious diseases and deadly forms of cancer.

The required research is based on company-developed exploration platforms. These innovative technologies allow the development of pharmacologically highly reactive substances. The potent drugs lead to targeted degradation of viral proteins to cure the disease.